SOX4 expression levels in urothelial bladder carcinoma

Pathology Research and Practice

Volumn 207, Issue 7, 2011, Pages 423-427

  Gunes, Sezgin ^a   Yegin, Zeynep ^a   Sullu, Yurdanur ^a   Buyukalpelli, Recep ^a   Bagci, Hasan ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Bladder carcinoma; Gene expression; SOX4 gene

Indexed keywords

TRANSCRIPTION FACTOR SOX4;

ADULT; AGED; ANALYTICAL PARAMETERS; APOPTOSIS; ARTICLE; BLADDER CARCINOMA; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TRANSCRIPTION REGULATION; TRANSITIONAL CELL CARCINOMA; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RNA, MESSENGER; SOXC TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 79959716767     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2011.05.005     Document Type: Article

References (18)

1. Vrooman O.P., Witjes J.A. Molecular markers for detection, surveillance and prognostication of bladder cancer. Int. J. Urol. 2009, 16:234-243.
2. Aaboe M., Birkenkamp-Demtroder K., Wiuf C., Sorensen F.B., Thykjaer T., Sauter G., ensen K.M., Dyrskjot L., Orntoft T. SOX4 expression in bladder carcinoma: clinical aspects and in vitro functional characterization. Cancer Res. 2006, 66:3434-3442.
3. Shen R., Pan S., Qi S., Lin X., Cheng S. Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 in gastric cancer. Biochem. Biophys. Res. Commun. 2010, 394:1047-1052.
4. Liu P., Ramachandran S., Ali Seyed M., Scharer C.D., Laycock N., Dalton W.B., Williams H., Karanam S., Datta M.W., Jaye D.L., Moreno C.S. Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells. Cancer Res. 2006, 66:4011-4019.
5. Hur W., Rhim H., Jung C.K., Kim J.D., Bae S.H., Jang J.W., Yang J.M., Oh S.T., Kim D.G., Wang H.J., Lee S.B., Yoon S.K. SOX4 overexpression regulates the p53-mediated apoptosis in hepatocellular carcinoma: clinical implication and functional analysis in vitro. Carcinogenesis 2010, 31:1298-1307.
6. Schilham M.W., Oosterwegel M.A., Moerer P., Ya J., de Boer P.A., van de Wetering M., Verbeek S., Lamers W.H., Kruisbeek A.M., Cumano A., Clevers H. Defects in cardiac outflow tract formation and pro-B-lymphocyte expansion in mice lacking Sox-4. Nature 1996, 380:711-714.
7. Schilham M.W., Moerer P., Cumano A., Clevers H.C. Sox-4 facilitates thymocyte differentiation. Eur. J. Immunol. 1997, 27:1292-1295.
8. Cheung M., Abu-Elmagd M., Clevers H., Scotting P.J. Roles of Sox4 in central nervous system development. Brain Res. Mol. Brain Res. 2000, 79:180-191.
9. Lopez-Beltran A., Montironi R. Non-invasive urothelial neoplasms: according to the most recent WHO classification. Eur. Urol. 2004, 46:170-176.
10. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
11. Pan X., Zhao J., Zhang W.N., Li H.Y., Mu R., Zhou T., Zhang H.Y., Gong W.L., Yu M., Man J.H., Zhang P.J., Li A.L., Zhang X.M. Induction of SOX4 by DNA damage is critical for p53 stabilization and function. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:3788-3793.
12. Medina P.P., Castillo S.D., Blanco S., Sanz-Garcia M., Largo C., Alvarez S., Yokota J., Gonzalez-Neira A., Benitez J., Clevers H.C., Cigudosa J.C., Lazo P.A., Sanchez-Cespedes M. The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer. Hum. Mol. Genet. 2009, 18:1343-1352.
13. Coogan C.L., Estrada C.R., Kapur S., Bloom K.J. HER-2/neu protein overexpression and gene amplification in human transitional cell carcinoma of the bladder. Urology 2004, 63(4):786-790.
14. Lebeau A., Deimling D., Kaltz C., Sendelhofert A., Iff A., Luthardt B., Untch M., Löhrs U. Her-2/neu analysis in archival tissue samples of human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridization. J. Clin. Oncol. 2001, 19(2):354-363.
15. Sauter G., Moch H., Moore D., Carroll P., Kerschmann R., Chew K., Mihatsch M.J., Gudat F., Waldman F. Heterogeneity of erbB-2 gene amplification in bladder cancer. Cancer Res. 1993, 53:2199-2203.
16. de Bont J.M., Kros J.M., Passier M.M., Reddingius R.E., Sillevis Smitt P.A., Luider T.M., den Boer M.L., Pieters R. Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis. Neuro-Oncology 2008, 10:648-660.
17. Neben K., Korshunov A., Benner A., Wrobel G., Hahn M., Kokocinski F., Golanov A., Joos S., Lichter P. Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival. Cancer Res. 2004, 64:3103-3111.
18. Dyrskjøt L., Ostenfeld M.S., Bramsen J.B., Silahtaroglu A.N., Lamy P., Ramanathan R., Fristrup N., Jensen J.L., Andersen C.L., Zieger K., Kauppinen S., Ulhøi B.P., Kjems J., Borre M., Orntoft T.F. Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res. 2009, 69:4851-4860.